Dingxin Capital

Dingxin Capital Co., Ltd. is a venture capital firm established in 2014 and headquartered in Shenzhen, China, with additional offices in Foshan, Hangzhou, and Dongguan. The firm specializes in early to middle stage, growth stage, and pre A-round investments, with a strong focus on sectors such as healthcare, consumer upgrade, and advanced technology. In the healthcare domain, Dingxin Capital targets high-end innovative medical devices and aims to address significant clinical needs in areas like cardiovascular, cerebrovascular, gastrointestinal, and orthopedic diseases. The firm is comprised of partners with extensive experience from prominent domestic investment institutions, fostering a robust investment management strategy to ensure sustainable growth.

Hu, Hui

Founding Partner

Deng, Ning

Partner

21 past transactions

Sitrus Technology

Series C in 2023
Sitrus Technology is a company created by returnees from overseas. Its primary goal is the creation and sale of a new generation of high-speed network connectivity processors. The company's new generation of high-speed network communication chips is a common key technology in the high-speed optical communication business. Cloud computing, the Internet of Things, big data, 5G connectivity, intelligent manufacturing, artificial intelligence networks, and other industries are all using it.

Ai Ma Biology

Angel Round in 2023
Ai Ma Biology is a small RNA nucleic acid drug developer, dedicated to the transformation of achievements in the field of biosynthesis.

Semitech

Series C in 2023
Semitech is an intelligent manufacturing system supplier focused on providing integrated manufacturing solutions for high-tech industries.

DHC Medical

Series A in 2022
DHC Medical is an assisted reproductive service provider

Future Meijia

Angel Round in 2022
Future Meijia is a digital system based on the area of interior design. It can enable businesses to open up links such as design, contract signing, payment, product selection, building, and delivery, and promote businesses and employees. Traditional decoration companies, whole-house customization businesses, and enterprises can all benefit from this.

Resnics

Series A in 2022
Resnics manufactures storage and network data processor chip solutions for the communications and Internet industries.

IMPACT Therapeutics

Series D in 2022
IMPACT Therapeutics creates new treatments to treat cancer and other life-threatening disorders. The firm is committed to the discovery and development of targeted anti-cancer treatments based on synthetic lethality, hence offering patients novel targeted anti-cancer drugs.

Resnics

Seed Round in 2021
Resnics manufactures storage and network data processor chip solutions for the communications and Internet industries.

Tongee Medical Technology

Venture Round in 2021
Tongee Medical Technology develops new medical technologies to treat various metabolic diseases, such as obesity, type 2 diabetes, and nonalcoholic fatty liver.

Zettasensing

Venture Round in 2020
Zettasensing is an integrated circuit company that focuses on the R&D and application of mid-to-high-end sensor chips. The company is based in Jingxi Zhongguancun Mentougou Science and Technology Park.

Etailor

Series A in 2019
Etailor is an online clothing brand that is committed to the introduction of European and American fit wear. It is a clothing service provider designated by many film and television organizations. Headquartered in Guangzhou, the center of the domestic apparel industry chain, it has a number of stores and central garment factories in Beijing, Shanghai, Guangzhou and Shenzhen. The team consists of senior red tailors and fashion designers with more than 20 years of experience. , Ping An Insurance underwriting, 30 days unconditional repair. Easy to change clothes is also the [Culture + Technology] project supported by the Propaganda Department of Guangdong Province. It is the only clothing company in China that realizes the central factory and ERP data management.

Jifu Medical

Series B in 2019
Zifu Medical is a national high-tech enterprise focusing on the research and development, production, sales and service of high-end medical products for the digestive tract. The company has built a professional R&D team and an international R&D management platform, has undertaken a number of national and Shenzhen technological innovation projects, and has obtained more than 100 national patents. Insisting on independent innovation and adhering to the spirit of craftsmanship, the "Dasheng" magnetically controlled capsule endoscope system series products independently developed for ten years have obtained the National Medical Products Administration NMPA Class III medical device registration and EU CE certification (EC certificate) , Widely praised by medical institutions.

Antaike Medical

Series A in 2018
Antaike Medical is a minimally invasive interventional medical equipment supplier.

E-SellTech

Seed Round in 2018
E-SellTech offers a platform that connects offline electronic screens, advertisers, and advertising audiences through the internet and internet of things technology. It provides management services for media owners and transforms traditional media through IOT and SAAS.

NepQD

Seed Round in 2018
Biological product company based in Jiangsu.

Arigin Medical

Series A in 2017
Arigin Medical is a medical 3D printing service provider company.

Haoshou Bang

Series A in 2017
Haoshou Bang provides hotel employment management systems.

GrowingUP

Angel Round in 2017
GrowingUP is an animator's studio operator. For both children and adults, the company creates movies, video games, virtual worlds, web apps, and mobile/iPod entertainment. The business produces, advertises, and broadcasts animated programs and films so that viewers can experience motion graphics and mixed media.

Jifu Medical

Series A in 2017
Zifu Medical is a national high-tech enterprise focusing on the research and development, production, sales and service of high-end medical products for the digestive tract. The company has built a professional R&D team and an international R&D management platform, has undertaken a number of national and Shenzhen technological innovation projects, and has obtained more than 100 national patents. Insisting on independent innovation and adhering to the spirit of craftsmanship, the "Dasheng" magnetically controlled capsule endoscope system series products independently developed for ten years have obtained the National Medical Products Administration NMPA Class III medical device registration and EU CE certification (EC certificate) , Widely praised by medical institutions.

Biosis Healing

Series B in 2016
Biosis Healing provides regenerative medicine materials and implantable medical device solutions covering clinical surgery. They offer products for minimally invasive surgery, hernia and abdominal wall surgery, dentistry, neurosurgery, and protective products. The company will continue to create advanced technologies and unique products, as well as promote advanced clinical technology and treatment approaches in collaboration with clinical specialists.

Focus Media

Series D in 2004
Focus Media (分众传媒) is a provider of product lines covering several media networks that aims at characteristic audiences such as video media in commercial buildings, terminal video media in stores, media in the elevators of apartments, outdoor large LED color screen media and advertising media of cinemas, and more. It owns several media networks such as video media in commercial buildings, terminal videos in stores, print media in the elevators of apartments, outdoor large LED color screen media, mobile wireless advertising media, internet advertising platforms, focus and direct-effect commercial DM media, database marketing channels, and more. Focus Media is highly identified in the industry with its unique business models, its property of segmenting, vividness and coerciveness in media disseminating.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.